Escitalopram Tablet, Film Coated
NDC Package 68001-592-00

11-digit billing NDC: 68001059200 · Billing unit: EA · 100 EA per package

Package Information

Escitalopram tablets are contraindicated in patients:taking MAOIs with escitalopram tablets or within 14 days of stopping treatment with escitalopram tablets because of an increased risk of serotonin syndrome. This formulation utilizes a tablet, film coated delivery system. Marketed by Bluepoint Laboratories, this product is identified by NDC 68001-592 and is authorized under FDA application ANDA078032.

Identification & Billing

NDC Package Code
68001-592-00
Package Description
100 TABLET, FILM COATED in 1 BOTTLE
Product Code
11-Digit Billing Format
68001059200
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Escitalopram
Non-Proprietary Name
Escitalopram
Substance Name
Escitalopram Oxalate
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Escitalopram tablets are contraindicated in patients:taking MAOIs with escitalopram tablets or within 14 days of stopping treatment with escitalopram tablets because of an increased risk of serotonin syndrome. The use of escitalopram tablets within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated [see Dosage and Administration( 2.7) and Warnings and Precautions( 5.2) ]. Starting escitalopram tablets in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome [see Dosage and Administration( 2.6) and Warnings and Precautions( 5.2) ]. taking pimozide [see Drug Interactions( 7) ]. with a hypersensitivity to escitalopram or citalopram or any of the inactive ingredients in escitalopram tablets.

Regulatory & Marketing

Labeler Name
Bluepoint Laboratories
Product Type
Human Prescription Drug
FDA Application #
ANDA078032
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-14-2023
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (68001-592). Click a package code to view its specific billing and regulatory data.

1000 TABLET, FILM COATED in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68001-592-00 identifies a specific commercial package of 100 tablet, film coated in 1 bottle of Escitalopram, a human prescription drug labeled by Bluepoint Laboratories. This tablet, film coated is formulated for oral use and contains escitalopram oxalate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bluepoint Laboratories on December 14, 2023. The current certification is valid through December 31, 2027.

How is this Bluepoint Laboratories product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68001059200. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68001-592-00
11-Digit CMS (5-4-2)
68001-0592-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.